Ovala, Inc.

Biotech Pittsburgh, PA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Pittsburgh, PA
Street
2366 Golden Mile Highway
Zip
15239

Offering

Total offering
$13M
Amount sold
$3.3M
First sale
Mar 16, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
8

How this filing compares

Ranked #6 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 2.4× the median.

Other Pennsylvania filings this week: 4401 Fund 4 LLC, Paragon Laboratories L.P., SEMPER VIC PARTNERS (QP), L. P., SEMPER VIC PARTNERS, L.P., 6 EMERY OWNER LLC

Leadership

Stephen Bollinger — Executive Officer (also: Director)

Brad Petersen — Director

Richard Petersen — Director

Michael Tovian — Director

Christopher Petersen — Director

John Sipple — Executive Officer

Jeffrey Quillen — Director

Filing details

Ovala, Inc. filed a Form D with the SEC on March 31, 2026.

Other newest Biotech companies

Other newest companies in Pennsylvania